New technology Intox Collect™ has been completed for collection and analysis of voice and facial recognition data using AI for alcohol and a ...
Hosted on MSN
Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform
Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a techbio company focused on central nervous system/CNS disorders, announced ...
This episode of the Pharmaron DMPK Insights Podcast Series sees Scott Summerfield (Senior Director and Head of Pharmaceutical Metabolism at Pharmaron) and Professor Elizabeth de Lange Professor in ...
AtaiBeckley Inc. (NASDAQ:ATAI) secured a spot on our list of the best penny stocks set to explode. AtaiBeckley Inc.
Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in CNS drug and device development, today announced it has successfully completed an inspection by ...
Nanomedicine. 2009;4(5):557-574. The BMVECs discussed previously make up 95% of brain vasculature; the remaining 5% is composed of the circumventricular regions of the CNS. These regions contain ...
LONDON, Dec 13 (Reuters) - GlaxoSmithKline Plc said on Thursday its neuroscience drug development programme had made significant advances, though development of a closely watched experimental insomnia ...
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) on Tuesday announced the primary analysis of its clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM), an aggressive ...
Polyrizon Ltd., a biotechnology company focused on intranasal drug delivery systems, has reported promising preclinical results for its hydrogel-based Trap & Target (T&T) platform, developed in ...
Zidovudine PBCA and MMA-SPM Emulsion polymerization and free-radical polymerization PBCA as a carrier; alcohol increases permeability of BMVECs to NPs [114] Indinavir Drug nanocrystals and lipoid E80 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results